{
  "created_at": "Sat Apr 10 23:28:50 +0000 2021",
  "id_str": "1381022190049632259",
  "full_text": "The government hopes that, if trials are successful, Cuba can produce 100m doses of its Soberana-2 vaccine by the end of the year https://t.co/MbdzIkMIbt",
  "display_text_range": [
    0,
    153
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/MbdzIkMIbt",
        "expanded_url": "https://econ.st/2Q7IIoo",
        "display_url": "econ.st/2Q7IIoo",
        "indices": [
          130,
          153
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 35,
  "favorite_count": 111,
  "possibly_sensitive": false,
  "original_created_at": "Sat Apr 10 23:12:02 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "キューバ政府は、試験が成功すれば、年末までに1億回分のソベラナ2ワクチンを製造できると期待しています。https://t.co/MbdzIkMIbt"
    },
    {
      "locale": "zh",
      "full_text": "政府希望，如果试验成功，古巴可以在年底前生产1亿剂Soberana-2疫苗https://t.co/MbdzIkMIbt。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "政府希望，如果試驗成功，古巴可以在年底前生產1億劑Soberana-2疫苗https://t.co/MbdzIkMIbt。"
    }
  ]
}